Trade Bumitama Agri - P8Zsg CFD

Trading Conditions

• Spread: 0.013
• Long position overnight feeLong position overnight feeMargin. Your investmentSGD 1,000.00Overnight feeCharges from full value of position-0.020845 %(-SGD 0.83)Trade size with leverage ~ SGD 5,000.00Short position overnight fee ~ SGD 4,000.00Go to platform: -0.020845%
• Short position overnight feeShort position overnight feeMargin. Your investmentSGD 1,000.00Overnight feeCharges from full value of position-0.001073 %(-SGD 0.04)Trade size with leverage ~ SGD 5,000.00Short position overnight fee ~ SGD 4,000.00Go to platform: -0.001073%
• Overnight fee time: 21:00 (UTC)
• Currency: SGD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: Singapore
• Commission on trade: 0%

• Margin. Your investment: SGD 1,000.00
• Overnight feeCharges from full value of position: -0.020845 %
  (-SGD 0.83)

• Margin. Your investment: SGD 1,000.00
• Overnight feeCharges from full value of position: -0.001073 %
  (-SGD 0.04)

Key Stats

• Prev. Close: 0.736
• Open: 0.751
• 1-Year Change: 16.98%
• Day's Range: 0.731 - 0.751

Bumitama Agri Company profile

About Bumitama Agri Ltd

Bumitama Agri Ltd. (Bumitama) is an Indonesia-based investment holding company. The Company is engaged in the crude palm oil (CPO) and palm kernel (PK) production with oil palm plantations in Indonesia. The Company has a total land bank of approximately 199,000 hectares in three provinces, including Central Kalimantan, West Kalimantan and Riau. The principal activities of its subsidiaries are that of investment holding, operating oil palm plantations and palm oil mills, as well as the production and trading of crude palm oil and related products. The Company's subsidiaries include PT Bumitama Energi Lestari, PT Bumitama Oleo Sentosa, PT Karya Makmur Bahagia, PT Hatiprima Agro, PT Gunajaya Karya Gemilang, PT Agro Sejahtera Manunggal and PT Gunajaya Ketapang Sentosa.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Bumitama Agri Ltd revenues increased 35% to RP12.249T. Net income increased 53% to RP1.721T. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Gain/loss from fair value of biological increase from RP25.69B to RP82.07B (income), Foreign exchange loss decrease of 23% to RP37.95B (expense).